Form 6-K Polyrizon Ltd. For: Jun 08

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

 

For the month of June 2026

 

Commission file number: 001-42375

 

Polyrizon Ltd.

(Translation of registrant’s name into English)

 

8 HaPnina Street

Raanana, 4321545, Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F ☐

 

 

 

CONTENTS

 

Attached hereto and incorporated by reference herein is the Notice of Annual General Meeting of Shareholders, Proxy Statement and Proxy Card for the Annual General Meeting of Shareholders of Polyrizon Ltd. (the “Company”) to be held on Monday, July 13, 2026 (the “Meeting”).

 

Only shareholders of record who hold ordinary shares, no par value, of the Company at the close of business on Monday, June 15, 2026, will be entitled to notice of and to vote at the Meeting and any postponements or adjournments thereof.

 

This Report of Foreign Private Issuer on Form 6-K and its exhibits, are incorporated by reference into the Company’s registration statements on Form S-8 (File No. 333-284410 and 333-288923) and Form F-3 (333-291368) filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

Exhibits No.
99.1		Notice and Proxy Statement for the Annual General Meeting to be held on July 13, 2026.
99.2		Proxy Card for the Annual General Meeting to be held on July 13, 2026.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Polyrizon Ltd.
Date: June 8, 2026	By	/s/ Tomer Izraeli
	Name:	Tomer Izraeli
	Title:	Chief Executive Officer

 

 

ATTACHMENTS / EXHIBITS

NOTICE AND PROXY STATEMENT FOR THE ANNUAL GENERAL MEETING TO BE HELD ON JULY 13, 2026

PROXY CARD FOR THE ANNUAL GENERAL MEETING TO BE HELD ON JULY 13, 2026

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Polyrizon patent application for nasal drug delivery platform published in U.S.
• Murj® Expands Global Footprint with Commercial Launch in Australia and New Zealand
• Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma